Semmelweis Publikációk
  • Főoldal

    • Kaló, Zoltán Semmelweis Egyetemi közleményei (2021-2026)

    Év:
    Rendezés:
    Szerzőség:
    Közlemények száma: 82
    1.
    Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions
    McQueen, RB;Inotai, A;Zemplenyi, A;Mendola, N;Németh, B;Kalo, Z
    D1
    VALUE IN HEALTH
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1016/j.jval.2023.09.2910 (Copy DOI)
    2.
    Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe
    Pitter, JG;Zemplényi, A;Babarczy, B;Németh, B;Kaló, Z;Vokó, Z
    D1
    GEROSCIENCE
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1007/s11357-023-00975-3 (Copy DOI)
    3.
    Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
    Fasseeh, AN;Elezbawy, B;Korra, N;Tannira, M;Dalle, H;Aderian, S;Abaza, S;Kaló, Z
    D1
    DERMATOLOGY AND THERAPY
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.1007/s13555-022-00819-6 (Copy DOI)
    4.
    Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
    Zemplényi, A;Tachkov, K;Balkanyi, L;Németh, B;Petykó, ZI;Petrova, G;Czech, M;Dawoud, D;Goettsch, W;Ibarluzea, IG;Hren, R;Knies, S;Lorenzovici, L;Maravic, Z;Piniazhko, O;Savova, A;Manova, M;Tesar, T;Zerovnik, S;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.3389/fpubh.2023.1088121 (Copy DOI)
    5.
    Rare disease challenges and potential actions in the Middle East
    Fasseeh, AN;Korra, N;Aljedai, A;Seyam, A;Almudaiheem, H;Al-Abdulkarim, HA;Janahi, M;Gamal, M;Fahmy, S;Aldallal, S;Abaza, S;Kalo, Z
    D1
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.1186/s12939-025-02388-4 (Copy DOI)
    6.
    Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
    Tachkov, K;Zemplenyi, A;Kamusheva, M;Dimitrova, M;Siirtola, P;Ponten, J;Nemeth, B;Kalo, Z;Petrova, G
    Q1
    FRONTIERS IN PUBLIC HEALTH
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.3389/fpubh.2022.921226 (Copy DOI)
    7.
    The hidden burden of atopic dermatitis in central and Eastern European countries
    Elezbawy, B;Kaló, Z;Fasseeh, A;Inotai, A;Nemeth, B;Agh, T
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.1080/14737167.2024.2416249 (Copy DOI)
    8.
    Framework for developing cost-effectiveness analysis threshold: the case of Egypt
    Fasseeh, AN;Korra, N;Elezbawy, B;Sedrak, AS;Gamal, M;Eldessouki, R;Eldebeiky, M;George, M;Seyam, A;Abourawash, A;Khalifa, AY;Shaheen, M;Abaza, S;Kalo, Z
    Q1
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1186/s42506-024-00159-7 (Copy DOI)
    9.
    Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates
    Alnaqbi, KA;Elshamy, AM;Gebran, N;Fahmy, S;Aldallal, S;Korra, N;Fasseeh, AN;Kaló, Z
    Q1
    VALUE IN HEALTH REGIONAL ISSUES
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1016/j.vhri.2024.101012 (Copy DOI)
    10.
    Healthcare financing in Egypt: a systematic literature review
    Fasseeh, A;ElEzbawy, B;Adly, W;ElShahawy, R;George, M;Abaza, S;ElShalakani, A;Kaló, Z
    Q1
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.1186/s42506-021-00089-8 (Copy DOI)
    11.
    Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
    Jakab, I;Dimitrova, M;Houÿez, F;Bereczky, T;Fövényes, M;Maravic, Z;Belina, I;Andriciuc, C;Tóth, K;Piniazhko, O;Hren, R;Gutierrez-Ibarluzea, I;Czech, M;Tesar, T;Niewada, M;Lorenzovici, L;Kamusheva, M;Manova, M;Savova, A;Mitkova, Z;Tachkov, K;Németh, B;Petykó, ZI;Dawoud, D;Delnoij, D;Knies, S;Goettsch, W;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.3389/fpubh.2023.1176200 (Copy DOI)
    12.
    Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer
    Inotai, A;Agh, T;Maris, R;Erdosi, D;Kovács, S;Kaló, Z;Senkus, E
    D1
    CANCER TREATMENT REVIEWS
    Folyóiratcikk / Összefoglaló cikk
    2021.
    DOI:10.1016/j.ctrv.2021.102264 (Copy DOI)
    13.
    Outcome-based reimbursement in Central-Eastern Europe and Middle-East
    Adám, I;Callenbach, M;Németh, B;Vreman, RA;Tollin, C;Pontén, J;Dawoud, D;Elvidge, J;Crabb, N;Van Doorn-Khosrovani, SBV;Pisters-van Roy, A;Vincziczki, A;Almomani, E;Vajagic, M;Oner, ZG;Matni, M;Fürst, J;Kahveci, R;Goettsch, WG;Kaló, Z
    Q1
    FRONTIERS IN MEDICINE
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.3389/fmed.2022.940886 (Copy DOI)
    14.
    Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions
    Aldallal, S;Farghaly, M;Fahmy, S;Alnaqbi, KA;Al Naeem, W;Alsaadi, M;Moukarzel, M;Fasseeh, AN;Korra, N;Abaza, S;Kaló, Z
    Q1
    BMJ OPEN
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1136/bmjopen-2024-090344 (Copy DOI)
    15.
    Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
    McQueen, RB;Mendola, ND;Jakab, I;Bennett, J;Nair, K;Németh, B;Inotai, A;Kaló, Z
    Q2
    PHARMACOECONOMICS-OPEN
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.1007/s41669-022-00376-w (Copy DOI)
    16.
    Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries
    Csanádi, M;Kaló, Z;Rutten-van Molken, M;Looman, W;Huic, M;Ercevic, D;Atanasijevic, D;Lorenzovici, L;Petryszyn, P;Pogány, G;Pitter, J;Zemplényi, A
    Q1
    HEALTH POLICY
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1016/j.healthpol.2022.08.012 (Copy DOI)
    17.
    Delayed payment schemes in Central-Eastern Europe and Middle-East
    Adám, I;Callenbach, M;Németh, B;Vreman, RA;Pontén, J;Strbad, T;Dawoud, D;Kostyuk, A;Seyam, A;Nagy, L;Goettsch, WG;Kaló, Z
    Q1
    FRONTIERS IN MEDICINE
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.3389/fmed.2022.940371 (Copy DOI)
    18.
    Coverage with evidence development for medical devices in Europe: Can practice meet theory?
    Drummond, M;Federici, C;Reckers-Droog, V;Torbica, A;Blankart, CR;Ciani, O;Kaló, Z;Kovács, S;Brouwer, W
    Q1
    HEALTH ECONOMICS
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1002/hec.4478 (Copy DOI)
    19.
    Impact of health technology assessment implementation with a special focus on middle-income countries
    Fasseeh, AN;Saragih, SM;Hayek, N;Brodovska, S;Ismail, A;ElShalakani, A;Abaza, S;Obeng, GD;Ameyaw, D;Kalo, Z
    Q1
    HEALTH POLICY AND TECHNOLOGY
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1016/j.hlpt.2022.100688 (Copy DOI)
    20.
    Underreported influenza mortality in Central and Eastern Europe hinders the extension of seasonal influenza vaccination programs in older adults
    Pitter, JG;Mihajlovic, J;Nagy, D;van der Schans, J;Vokó, Z;Kaló, Z
    D1
    VACCINE
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.1016/j.vaccine.2025.127184 (Copy DOI)
    21.
    Burden of Chronic Heart Failure in Romania
    Lorenzovici, L;Barzan-Székely, A;Farkas-Ráduly, S;Pana, BC;Csanádi, M;Chiriac, ND;Kaló, Z
    Q2
    HEALTHCARE
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.3390/healthcare10010107 (Copy DOI)
    22.
    The Role of Patient Experience in the Value Assessment of Complex Technologies - Do HTA Bodies Need to Reconsider How Value is Assessed?
    Sarri, G;Freitag, A;Szegvari, B;Mountian, I;Brixner, D;Bertelsen, N;Kaló, Z;Upadhyaya, S
    Q1
    HEALTH POLICY
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1016/j.healthpol.2021.03.006 (Copy DOI)
    23.
    A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt
    Elezbawy, B;Fasseeh, AN;Sedrak, A;Eldessouki, R;Gamal, M;Eldebeiky, M;Amer, H;Akeel, S;Morsy, A;Amin, A;Shafik, A;Abaza, S;Kaló, Z
    Q1
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1186/s40545-022-00414-2 (Copy DOI)
    24.
    Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan
    Almomani, E;Alabbadi, I;Fasseeh, A;Al-Qutob, R;Al-Sharu, E;Hayek, N;Tarawneh, MR;Kaló, Z
    Q2
    VALUE IN HEALTH REGIONAL ISSUES
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1016/j.vhri.2021.01.003 (Copy DOI)
    25.
    Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges
    Daubner-Bendes, R;Kovács, S;Niewada, M;Huic, M;Drummond, M;Ciani, O;Blankart, CR;Mandrik, O;Torbica, A;Yfantopoulos, J;Petrova, G;Holownia-Voloskova, M;Taylor, RS;Al, M;Piniazhko, O;Lorenzovici, L;Tarricone, R;Zemplényi, A;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.3389/fpubh.2020.612410 (Copy DOI)
    26.
    Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
    Dimitrova, M;Jakab, I;Mitkova, Z;Kamusheva, M;Tachkov, K;Nemeth, B;Zemplenyi, A;Dawoud, D;Delnoij, DMJ;Houÿez, F;Kalo, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.3389/fpubh.2022.922708 (Copy DOI)
    27.
    Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
    Incze, A;Kalo, Z;Espin, J;Kiss, E;Kessabi, S;Garrison, LP
    Q1
    FRONTIERS IN PHARMACOLOGY
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.3389/fphar.2022.815029 (Copy DOI)
    28.
    Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries
    Kovács, S;Kaló, Z;Daubner-Bendes, R;Kolasa, K;Hren, R;Tesar, T;Reckers-Droog, V;Brouwer, W;Federici, C;Drummond, M;Zemplényi, AT
    Q1
    HEALTH ECONOMICS
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1002/hec.4504 (Copy DOI)
    29.
    Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers
    Otte, M;Dauben, HP;Ahn, J;Ibarluzea, IG;Drummond, M;Simoens, S;Kalo, Z;Suh, DC
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1080/14737167.2024.2398482 (Copy DOI)
    30.
    Regulatory and HTA early dialogues in medical devices
    Blankart, CR;Dams, F;Penton, H;Kaló, Z;Zemplényi, A;Shatrov, K;Iskandar, R;Federici, C
    Q1
    HEALTH POLICY
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1016/j.healthpol.2021.07.010 (Copy DOI)
    31.
    A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply
    Németh, G;Mágó, ML;Kaló, Z;Lám, J;Balogh, T;Brodszky, V
    Q1
    FRONTIERS IN MEDICINE
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.3389/fmed.2023.1282698 (Copy DOI)
    32.
    Cost-Effectiveness of Bariatric Surgery in Patients Living with Obesity and Type 2 Diabetes
    Kovács, G;Mohos, E;Kis, JT;Tabák, A;Gerendy, P;Pettkó, J;Nagy, D;Gyorbíró, D;Kaló, Z
    Q2
    JOURNAL OF DIABETES RESEARCH
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.1155/2023/9686729 (Copy DOI)
    33.
    Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region
    Elezbawy, B;Fasseeh, AN;Fouly, E;Tannira, M;Dalle, H;Aderian, S;Abu Esba, LC;Al Abdulkarim, H;Ammoury, A;Altawil, E;Al Turaiki, A;Albreiki, F;Al-Haddab, M;Al-Lafi, A;Alowayesh, M;Al-Sheikh, A;Elsayed, M;Elshamy, A;Eshmawi, M;Farag, A;Hamadah, I;Hedibel, M;Kannenberg, S;Karam, R;Metni, M;Raboobee, N;Steinhoff, M;Abaza, S;Farghaly, M;Kaló, Z
    D1
    DERMATOLOGY AND THERAPY
    Folyóiratcikk / Összefoglaló cikk
    2023.
    DOI:10.1007/s13555-022-00857-0 (Copy DOI)
    34.
    Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE
    Farghaly, MN;Al Dallal, SAM;Fasseeh, AN;Monsef, NA;Suliman, EAMA;Tahoun, MA;Abaza, S;Kaló, Z
    Q1
    FRONTIERS IN PHARMACOLOGY
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.3389/fphar.2021.680737 (Copy DOI)
    35.
    Systematic literature review of health economic models developed for multiple myeloma to support future analyses
    Choon-Quinones, M;Zelei, T;Németh, B;Tóth, M;Jia, XY;Barnett, M;Keown, P;Durie, B;Harousseau, JL;Hose, D;Kaló, Z
    Q1
    JOURNAL OF MEDICAL ECONOMICS
    Folyóiratcikk / Összefoglaló cikk
    2023.
    DOI:10.1080/13696998.2022.2144056 (Copy DOI)
    36.
    Maximizing the benefits of using biosimilars in Egypt
    Fasseeh, AN;Elezbawy, B;El-Fass, KA;GamaI, M;Seyam, A;Hayek, N;Rahman, NA;Abdelhamid, S;Fasseeh, N;Saad, AS;Elagamy, A;Mahmoud, A;Sedrak, AS;Elshazly, K;Eldebeiky, M;Talaat, M;Mohamed, NM;Abdelaziz, RA;Refaat, R;Akeel, S;Abaza, S;Kalo, Z
    Q1
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.1186/s40545-023-00581-w (Copy DOI)
    37.
    Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions
    Almomani, E;Hammad, EA;AlQutob, R;Abu Hammour, K;Al-Sharu, E;Abu-Shaer, M;Alabbadi, I;Kaló, Z
    Q2
    VALUE IN HEALTH REGIONAL ISSUES
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1016/j.vhri.2022.07.006 (Copy DOI)
    38.
    Patient and Payer Preferences for Additional Value Criteria
    Jakab, I;Whittington, MD;Franklin, E;Raiola, S;Campbell, JD;Kaló, Z;McQueen, RB
    Q1
    FRONTIERS IN PHARMACOLOGY
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.3389/fphar.2021.690021 (Copy DOI)
    39.
    Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
    Kovács, S;Németh, B;Erdosi, D;Brodszky, V;Boncz, I;Kaló, Z;Zemplényi, A
    Q1
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1007/s40258-021-00710-z (Copy DOI)
    40.
    Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region
    Elezbawy, B;Farghaly, M;Al Lafi, A;Gamal, M;Metni, M;Visser, W;Al-Abdulkarim, H;Hedibel, M;Fasseeh, AN;Abaza, S;Kalo, Z
    Q1
    VALUE IN HEALTH REGIONAL ISSUES
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1016/j.vhri.2024.100987 (Copy DOI)
    41.
    Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids
    Choon-Quinones, M;Hose, D;Kaló, Z;Zelei, T;Harousseau, JL;Durie, B;Keown, P;Barnett, M;Jakab, I
    D1
    VALUE IN HEALTH
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.1016/j.jval.2022.04.003 (Copy DOI)
    42.
    Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings
    Petykó, ZI;Kaló, Z;Espin, J;Podrazilová, K;Tesar, T;Maniadakis, N;Fricke, FU;Inotai, A
    Q2
    COST EFFECTIVENESS AND RESOURCE ALLOCATION
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1186/s12962-021-00311-6 (Copy DOI)
    43.
    Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000
    Inotai, A;Nagy, D;Kaló, Z;Vokó, Z
    Q1
    QUALITY OF LIFE RESEARCH
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1007/s11136-024-03699-9 (Copy DOI)
    44.
    Beyond medicines' barriers: exploring the true cost of multiple myeloma
    Choon-Quinones, M;Zelei, T;Barnett, M;Keown, P;Durie, B;Kalo, Z;Almasi, T;Harousseau, JL;Hose, D
    Q2
    JOURNAL OF MEDICAL ECONOMICS
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.1080/13696998.2022.2133823 (Copy DOI)
    45.
    A roadmap toward implementing health technology assessment in Egypt
    Fasseeh, AN;Elezbawy, B;Gamal, M;Seyam, A;Abourawash, A;George, M;Anwar, M;Amin, M;Khalifa, AY;Elshalakani, A;Hatem, A;Abdelhamid, S;Elsamouly, H;Fasseeh, N;Adel, R;Dawood, H;Abaza, S;Kaló, Z
    Q1
    FRONTIERS IN PUBLIC HEALTH
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.3389/fpubh.2022.896175 (Copy DOI)
    46.
    A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt
    Elezbawy, B;Fasseeh, AN;Németh, B;Gamal, M;Eldebeiky, M;Refaat, R;Taha, A;Rabiea, S;Abdallah, M;Ramadan, S;Noaman, H;Eldin, AB;Mostafa, H;Nouh, S;Zaki, A;Abdelrahman, M;Abaza, S;Kalò, Z
    Q1
    BMC MEDICAL INFORMATICS AND DECISION MAKING
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1186/s12911-022-02025-y (Copy DOI)
    47.
    A roadmap towards implementing health technology assessment in Oman
    Al Rashdi, I;Al Balushi, S;Al Shuaili, A;Al Rashdi, S;Al Bulushi, NI;Al Kindi, AI;Al Salmi, Q;Al Sabti, H;Korra, N;Abaza, S;Fasseeh, AN;Kaló, Z
    Q2
    JOURNAL OF HEALTH ORGANIZATION AND MANAGEMENT
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1108/JHOM-01-2024-0012 (Copy DOI)
    48.
    Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making
    Németh, B;Kamusheva, M;Mitkova, Z;Petykó, ZI;Zemplényi, A;Dimitrova, M;Tachkov, K;Balkányi, L;Czech, M;Dawoud, D;Goettsch, W;Hren, R;Knies, S;Lorenzovici, L;Maravic, Z;Piniazhko, O;Zerovnik, S;Kaló, Z
    Q2
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.57264/cer-2022-0157 (Copy DOI)
    49.
    Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers
    Kamusheva, M;Németh, B;Zemplényi, A;Kaló, Z;Elvidge, J;Dimitrova, M;Pontén, J;Tachkov, K;Mitkova, Z
    Q2
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH
    Folyóiratcikk / Összefoglaló cikk
    2022.
    DOI:10.2217/cer-2022-0065 (Copy DOI)
    50.
    The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia
    Elezbawy, B;Fasseeh, AN;Fouly, E;Abu Esba, LC;Al Abdulkarim, H;Al-Haddab, M;Al-Sheikh, A;Altawil, E;Al Turaiki, A;Eshmawi, M;Hamadah, I;Tannira, M;Dalle, H;Aderian, S;Roshdy, A;Jaheen, A;Hamad, T;Abaza, S;Kaló, Z
    Q2
    JOURNAL OF MEDICAL ECONOMICS
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1080/13696998.2022.2152234 (Copy DOI)
    51.
    Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
    Kaló, Z;Petykó, ZI;Fricke, FU;Maniadakis, N;Tesar, T;Podrazilová, K;Espin, J;Inotai, A
    Q2
    COST EFFECTIVENESS AND RESOURCE ALLOCATION
    Folyóiratcikk / Összefoglaló cikk
    2021.
    DOI:10.1186/s12962-021-00296-2 (Copy DOI)
    52.
    Health technology assessment in T?rkiye: Current status and perspectives on future implementation
    Atikeler, EK;Fasseeh, AN;Mantel-Teeuwisse, AK;Çaliskan, Z;Öner, ZG;Kizilay, H;Kalo, Z;Goettsch, W
    Q1
    HEALTH POLICY AND TECHNOLOGY
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.1016/j.hlpt.2022.100701 (Copy DOI)
    53.
    Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases
    Inotai, A;Kaló, Z;Petykó, Z;Gyöngyoesi, K;O'Keeffe, DT;Czech, M;Agh, T
    Q1
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.3390/jcdd11070186 (Copy DOI)
    54.
    Retrospective cost-utility analysis of the Non-typhoidal Salmonella control programme in Hungary
    Országh, E;Pitter, JG;Kaló, Z;Vokó, Z;Józwiak, A
    D1
    FOOD CONTROL
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1016/j.foodcont.2020.107529 (Copy DOI)
    55.
    Proposal for capturing patient experience through extended value frameworks o f health technologies
    Inotai, A;Jakab, I;Brixner, D;Campbell, JD;Hawkins, N;Kristensen, LE;Charokopou, M;Mountian, I;Szegvari, B;Kaló, Z
    D1
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY
    Folyóiratcikk / Összefoglaló cikk
    2021.
    DOI:10.18553/jmcp.2021.27.7.936 (Copy DOI)
    56.
    Tradeoffs When Building and Running Cohort and Patient-Level Markov Simulation Models
    Nagy, B;Fasseeh, AN;Campbell, JD;Kaló, Z;El-Fass, KA;Hren, R;Németh, B
    Q2
    ALGORITHMS
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.3390/a17120546 (Copy DOI)
    57.
    Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control
    Pitter, JG;Moizs, M;Ezer, ÉS;Lukács, G;Szigeti, A;Repa, I;Csanádi, M;Rutten-van Mölken, MPMH;Islam, K;Kaló, Z;Vokó, Z
    Q1
    PLOS ONE
    Folyóiratcikk / Szakcikk
    2022.
    DOI:10.1371/journal.pone.0276719 (Copy DOI)
    58.
    Early palliative care associated with lower costs for adults with advanced cancer: evidence from Hungary
    Zemplényi, AT;Csikós, A;Fadgyas-Freyler, P;Csanádi, M;Kaló, Z;Pozsgai, É;Rutten-van Mölken, M;Pitter, JG
    Q3
    EUROPEAN JOURNAL OF CANCER CARE
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1111/ecc.13473 (Copy DOI)
    59.
    Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
    Lorenzovici, L;Szilberhorn, L;Farkas-Ráduly, S;Gasparik, AI;Precup, AM;Nagy, AG;Niemann, CU;Aittokallio, T;Kaló, Z;Csanádi, M
    D1
    BIODRUGS
    Folyóiratcikk / Összefoglaló cikk
    2023.
    DOI:10.1007/s40259-023-00583-9 (Copy DOI)
    60.
    Incremental cost of premature birth - a public health care payer perspective from Hungary
    Kovács, G;Abonyi-Tóth, Z;Fadgyas-Freyler, P;Kaló, Z
    Q1
    BMC HEALTH SERVICES RESEARCH
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.1186/s12913-023-09697-w (Copy DOI)
    61.
    Implementation of evidence-based health policy in the field of integrated care The planning process of the Hungarian National Resource Centre for Rare Diseases
    Gábor, P;Marcell, C;György, PJ;Tamás, ZA;Éva, B;Zsuzsanna, B;Judit, K;Petra, FF;Lajos, S;Zoltán, K
    Q4
    ORVOSI HETILAP
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.1556/650.2021.32244 (Copy DOI)
    62.
    Early-stage assessment of investigational digital technologies in mental health: a guide for innovators
    Kaló, Z;Imre, A;Tatár, M;Nagy, B
    Q1
    PSYCHIATRY RESEARCH
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.1016/j.psychres.2025.116634 (Copy DOI)
    63.
    Optimization of pharmaceutical research and development by early-phase assessment of investigational medicinal products
    Kaló, Z;Imre, A;Varga, G;Kovács, S;Tímár, G;Nagy, B
    Q1
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    Folyóiratcikk / Összefoglaló cikk
    2025.
    DOI:10.1002/bcp.70192 (Copy DOI)
    64.
    The applicability of health technology assessment and risk-benefit analysis in the field of food safety
    Országh, E;Józwiak, A;Süth, M;Micsinai, A;Urbányi, B;Vokó, Z;Kaló, Z;Pitter, JG
    Q4
    MAGYAR ALLATORVOSOK LAPJA
    Folyóiratcikk / Összefoglaló cikk
    2021.
    65.
    The eyes of the beholder: Perceived barriers to successful drug repurposing
    Petykó, ZI;Hosszú, D;Csanádi, M;Gyöngyösi, K;Obeng, GD;Ameyaw, D;Dóczi, TI;Kaló, Z;Lo, DC;van der Meer, HG;Pantziarka, P;Inotai, A
    D1
    BRITISH JOURNAL OF PHARMACOLOGY
    Folyóiratcikk / Összefoglaló cikk
    2026.
    DOI:10.1111/bph.70243 (Copy DOI)
    66.
    Methodological guidelines for Health Technology Assessment in Oman
    Wani, S;Alsabti, H;Allamki, S;Almandhari, A;Alhajji, S;Alrashdi, I;Al Sabri, R;Alqassabi, A;Alzaabi, A;Almaashani, A;Ashuaili, A;Rasool, A;Alkindi, A;Salman, B;Alzadjali, F;Al Rahbi, K;Almutawa, K;Alansari, M;Alkharusi, M;Albulushi, N;Alghadani, R;Aljaber, R;Almuaini, S;Alkindi, S;Alzawamri, S;Albalushi, S;Al Lawati, S;Alsalti, Z;Albalushi, H;Fasseeh, AN;Kalo, Z
    Q1
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.1080/20523211.2025.2596523 (Copy DOI)
    67.
    Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars
    Otte, M;Kaló, Z;Al-Omar, HA;Boysen, M;Chen, YY;Etges, APBD;Kockaya, G;Gutierrez-Ibarluzea, I;Seyam, AM;Mullen, D;Dauben, HP
    Q1
    FRONTIERS IN PHARMACOLOGY
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.3389/fphar.2025.1599013 (Copy DOI)
    68.
    Implementation roadmap of health technology assessment in Iran
    Talebzadeh, B;Ghazbani, A;Fasseeh, AN;Jame, SZB;Hejrypour, SZ;Karami, K;Sarooeyeh, F;Behzadifar, M;Kaló, Z
    Q2
    HEALTH POLICY AND TECHNOLOGY
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.1016/j.hlpt.2025.101015 (Copy DOI)
    69.
    Social framework to judge the importance of breast cancer
    Pozsár, ZR;Tóth, K;Moizs, M;Révész, J;Tatár-Kiss, K;Tittmann, J;Nikolényi, A;Kovács, AA;Mátrai, T;Szabó, BJ;Kovács, EH;Czene, C;Hosszú, D;Bögös, A;Nguyen, TT;Bartha, JZ;Agh, T;Kaló, Z;Dank, M
    Q1
    JOURNAL OF CANCER POLICY
    Folyóiratcikk / Szakcikk
    2026.
    DOI:10.1016/j.jcpo.2025.100679 (Copy DOI)
    70.
    Cost Utility Modeling of Reducing Waiting Times for Elective Surgical Interventions: Case Study of Egyptian Initiative
    Fasseeh, AN;Salem, AA;Khalifa, AY;ElBerri, AK;Abaza, N;Elezbawy, B;Al Qasseer, N;Nagy, B;Kaló, Z;Németh, B;Hren, R
    Q2
    HEALTHCARE
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.3390/healthcare13131619 (Copy DOI)
    71.
    Extended Analysis of the Hospitalization Cost and Economic Burden of COVID-19 in Romania
    Bradács, A;Lorenzovici, L;Bába, LI;Kaló, Z;Farkas-Ráduly, S;Precup, AM;Somodi, K;Gheorghe, M;Calcan, A;Tar, G;Adam, O;Briciu, VT;Florescu, SA;Ianosi, ES;Garbovan, O;Siriopol, DC;Vokó, Z
    Q2
    HEALTHCARE
    Folyóiratcikk / Szakcikk
    2025.
    DOI:10.3390/healthcare13090982 (Copy DOI)
    72.
    Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters' countries
    Tachkov, K;Somolinos-Simón, F;Tapia-Galisteo, J;Hernando, ME;García-Sáez, G;Dimitrova, M;Kamusheva, M;Mitkova, Z;Petyko, Z;Nemeth, B;Kalo, Z;Tesar, T;Paveliu, MS;Piniazhko, O;Lipska, I;Turcu-Stiolica, A;Savova, A;Manova, M;Hren, R;Bonca, PD;Knies, S;Stanak, M;Dolezal, T;Vitezic, D;Petrova, G
    Q3
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1080/13102818.2024.2371354 (Copy DOI)
    73.
    Understanding of the Readiness for HTA Implementation in Jordan as a Step Towards Universal Health Coverage
    Alamer, Mira; Kaló, Zoltán; Schuller, Tara; Almomani, Emad; AlQutob, Raeda;
    Q4
    JORDAN MEDICAL JOURNAL 0446-9283 2664-8091
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.35516/jmj.v57i1.1103 (Copy DOI)
    74.
    Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook
    Callenbach, MHE;Adám, L;Vreman, RA;Németh, B;Kaló, Z;Goettsch, WG
    D1
    DRUG DISCOVERY TODAY
    Folyóiratcikk / Összefoglaló cikk
    2023.
    DOI:10.1016/j.drudis.2022.103433 (Copy DOI)
    75.
    Designing a Roadmap for Health Technology Assessment Implementation in Algeria
    Hedibel, M;Ghanassi, FZ;El-Fass, KA;Fasseeh, AN;Abaza, S;Kaló, Z
    CUREUS JOURNAL OF MEDICAL SCIENCE
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.7759/cureus.65558 (Copy DOI)
    76.
    Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries
    Kaló, Z;Niewada, M;Bereczky, T;Goettsch, W;Vreman, RA;Xoxi, E;Trusheim, M;Callenbach, MHE;Nagy, L;Simoens, S
    Q2
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.1080/14737167.2023.2282680 (Copy DOI)
    77.
    Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs
    Alnaqbi, KA;Elezbawy, B;Fasseeh, AN;Bangash, AR;Elshamy, A;Shendi, H;Aftab, MI;Almarshoodi, M;Gebran, N;Aldhaheri, N;Fahmy, SA;Al Dallal, S;Al Naeem, W;Abaza, S;Kaló, Z
    CUREUS JOURNAL OF MEDICAL SCIENCE
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.7759/cureus.55215 (Copy DOI)
    78.
    Development of public financing initiatives in pharmaceutical R&D – is it the key to the future of medicine?
    Ádám, Ildikó; Kaló, Zoltán;
    KALEIDOSCOPE: MŰVELŐDÉS- TUDOMÁNY- ÉS ORVOSTÖRTÉNETI FOLYÓIRAT 2062-2597
    Folyóiratcikk / Szakcikk
    2021.
    DOI:10.17107/KH.2021.22.316-324 (Copy DOI)
    79.
    A bariátriai műtétek egészségpolitikai szerepe a 2-es típusú cukorbetegségben szenvedő elhízott betegek ellátásában
    Kovács, Gábor; Mohos, Elemér; Kis, János Tibor; Tabák, Ádám; Gerendy, Péter; Dózsa, Csaba; Dózsa, Katalin; Pettkó, Judit; Ujhelyi, Krisztina; Kaló, Zoltán;
    IME 1588-6387 1789-9974
    Folyóiratcikk / Szakcikk
    2023.
    DOI:10.53020/IME-2023-302 (Copy DOI)
    80.
    Regulatory Framework for Supporting the Integration and Use of Biosimilars in the Private Healthcare System of the United Arab Emirates (UAE)
    Farghaly, Mohamed; El-Fass, Kareem A; Amin, Nabil; Qaiser, Shazia; Attallah, Mona; Farooq, Qasim; Badr, Mohamed; Al, Dallal Sara; Farah, Mona; Nathwani, Rahul; Alansari, Atheer; Jazzar, Ahmad; Reda, Ashraf; Lee, Martin; Abogamal, Ahmed; Fasseeh, Ahmad N; Kaló, Zoltán;
    CUREUS 2168-8184
    Folyóiratcikk / Szakcikk
    2024.
    DOI:10.7759/cureus.74581 (Copy DOI)
    81.
    Economic Benefits of Reduced Waiting Times for Elective Surgeries: A Systematic Literature Review
    Hren, Rok; Abaza, Nada; Elezbawy, Baher; Khalifa, Ahmed; Fasseeh, Ahmad N; Al, Gasseer Naeema; Kaló, Zoltán;
    CUREUS 2168-8184
    Folyóiratcikk / Összefoglaló cikk
    2025.
    DOI:10.7759/cureus.79417 (Copy DOI)
    82.
    Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries
    Kaló, Zoltán; Petrova, Guenka; Németh, Bertalan; Bonča, Petra Došenović; Delnoij, Diana; Bennett, Alastair; Tachkov, Konstantin; Zhang, Yingying; Kreif, Noemi; Knies, Saskia; Lipska, Iga; Tesar, Tomas; Mitkova, Zornitsa; Ponten, Johan; Viberg, Anders; Paveliu, Marian-Sorin; Piniazkho, Oresta; Turcu-Stiolica, Adina; Doležal, Tomáš; Staňák, Michal; Almadiyeva, Alima; Hren, Rok; Vitezić, Dinko; Petykó, Zsuzsanna; Goettsch, Wim; Manca, Andrea;
    Q2
    HEALTH SCIENCE REPORTS 2398-8835
    Folyóiratcikk / Szakcikk
    2026.
    DOI:10.1002/hsr2.71534 (Copy DOI)

    Navigáció

    Főoldal

    Közlemények keresése

    Szervezeti egységek rangsora

    Szerzők rangsora

    Szerző keresése

    Közelmúltban SJR D1 folyóiratban megjelent közlemények

    Kiváló egyetemi közlemények

    Top szakterületi idézettségi arányú közlemények

    A Semmelweis Egyetem "Highly cited" közleményei

    Semmelweis Publications
    Megjelenés azonosító: 2026_2
    Szervezeti egységek adatainak utolsó frissítése: 2025.02.04
    Szerzők adatainak utolsó frissítése: 2025.02.10
    (c) Semmelweis Egyetem - Központi Könyvtár